Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
about
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction deviceMembrane properties in small cutaneous nerve fibers in humans.
P2860
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
@en
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
@nl
type
label
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
@en
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
@nl
prefLabel
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
@en
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
@nl
P2093
P2860
P1476
Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
@en
P2093
D Fennelly
D Tryfonopoulos
J C McHugh
S Connolly
P2860
P304
P356
10.1111/J.1365-2354.2012.01361.X
P407
P577
2012-05-17T00:00:00Z